 | • レポートコード：MRC2312MG03644 • 出版社/出版日：Market Monitor Global / 2023年12月 • レポート形態：英文、PDF、70ページ • 納品方法：Eメール（納期：3営業日） • 産業分類：医薬品 |
| Single User | ￥487,500 (USD3,250) | ▷ お問い合わせ |
| Enterprise User | ￥731,250 (USD4,875) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査レポートは次の情報を含め、世界のプロイロムチリン抗生物質市場規模と予測を収録しています。・世界のプロイロムチリン抗生物質市場：売上、2018年-2023年、2024年-2029年 ・世界のプロイロムチリン抗生物質市場：販売量、2018年-2023年、2024年-2029年 ・世界のトップ5企業、2022年 世界のプロイロムチリン抗生物質市場は2022年に000Mドルと評価され、予測期間中に000％のCAGRで2029年までに000Mドルに達すると予測されています。米国市場は2022年に000Mドルと推定されており、中国は2029年までに000Mドルに達すると予測されています。「プレミックス」セグメントは今後6年間、000%のCAGRで2029年までに000Mドルに成長すると予測されています。 プロイロムチリン抗生物質のグローバル主要企業は、Sunny Biotech、 Hebei Weiyuan、 Shandong Shengli、 Shandong Lukang、 Qingdao Dierman、 Qilu Pharma、 Huvepharma、 Novartis、 Vethellas、 Elancoなどです。2022年にトップ5企業がグローバル売上シェアの約000%を占めています。 MARKET MONITOR GLOBAL（MMG）は、プロイロムチリン抗生物質のメーカー、サプライヤー、流通業者、および業界の専門家を調査しました。これには、販売量、売上、需要、価格変動、製品タイプ、最近の動向と計画、産業トレンド、成長要因、課題、阻害要因、潜在的なリスクなどが含まれます。 【セグメント別市場分析】 世界のプロイロムチリン抗生物質市場：タイプ別、2018年-2023年、2024年-2029年 世界のプロイロムチリン抗生物質市場：タイプ別市場シェア、2022年 ・プレミックス、API粉末 世界のプロイロムチリン抗生物質市場：用途別、2018年-2023年、2024年-2029年 世界のプロイロムチリン抗生物質市場：用途別市場シェア、2022年 ・家畜、家禽 世界のプロイロムチリン抗生物質市場：地域・国別、2018年-2023年、2024年-2029年 世界のプロイロムチリン抗生物質市場：地域別市場シェア、2022年 ・北米：アメリカ、カナダ、メキシコ ・ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア ・アジア：中国、日本、韓国、東南アジア、インド ・南米：ブラジル、アルゼンチン ・中東・アフリカ：トルコ、イスラエル、サウジアラビア、UAE 【競合分析】 また、当レポートは主要な市場参加者の分析を提供します。 ・主要企業におけるプロイロムチリン抗生物質のグローバル売上、2018年-2023年 ・主要企業におけるプロイロムチリン抗生物質のグローバル売上シェア、2022年 ・主要企業におけるプロイロムチリン抗生物質のグローバル販売量、2018年-2023年 ・主要企業におけるプロイロムチリン抗生物質のグローバル販売量シェア、2022年 さらに、当レポートは主要企業のプロファイルを提示します。 Sunny Biotech、 Hebei Weiyuan、 Shandong Shengli、 Shandong Lukang、 Qingdao Dierman、 Qilu Pharma、 Huvepharma、 Novartis、 Vethellas、 Elanco ************************************************************* ・調査・分析レポートの概要 プロイロムチリン抗生物質市場の定義 市場セグメント 世界のプロイロムチリン抗生物質市場概要 当レポートの特徴・ベネフィット 調査手法と情報源 ・世界のプロイロムチリン抗生物質市場規模 世界のプロイロムチリン抗生物質市場規模：2022年 VS 2029年 世界のプロイロムチリン抗生物質市場規模と予測 2018年-2029年 ・競争状況 グローバルトップ企業 売上ベースでのグローバルトップ企業 企業別グローバルでのプロイロムチリン抗生物質の売上 グローバルトップ3およびトップ5企業、2022年売上ベース グローバル企業のプロイロムチリン抗生物質製品タイプ グローバルにおけるティア1、ティア2、ティア3企業 ・タイプ別市場分析 タイプ区分：プレミックス、API粉末 プロイロムチリン抗生物質のタイプ別グローバル売上・予測 ・用途別市場分析 用途区分：家畜、家禽 プロイロムチリン抗生物質の用途別グローバル売上・予測 ・地域別市場分析 地域別プロイロムチリン抗生物質市場規模 2022年と2029年 地域別プロイロムチリン抗生物質売上・予測 北米市場：アメリカ、カナダ、メキシコ ヨーロッパ市場：ドイツ、フランス、イギリス、イタリア、ロシア アジア市場：中国、日本、韓国、東南アジア、インド 南米市場：ブラジル、アルゼンチン 中東・アフリカ市場：トルコ、イスラエル、サウジアラビア、UAE ・主要企業のプロファイル（企業概要、事業概要、主要製品、売上、ニュースなど） Sunny Biotech、 Hebei Weiyuan、 Shandong Shengli、 Shandong Lukang、 Qingdao Dierman、 Qilu Pharma、 Huvepharma、 Novartis、 Vethellas、 Elanco ... |
This research report provides a comprehensive analysis of the Pleuromutilin Antibiotic market, focusing on the current trends, market dynamics, and future prospects. The report explores the global Pleuromutilin Antibiotic market, including major regions such as North America, Europe, Asia-Pacific, and emerging markets. It also examines key factors driving the growth of Pleuromutilin Antibiotic, challenges faced by the industry, and potential opportunities for market players.
The global Pleuromutilin Antibiotic market has witnessed rapid growth in recent years, driven by increasing environmental concerns, government incentives, and advancements in technology. The Pleuromutilin Antibiotic market presents opportunities for various stakeholders, including Livestock, Poultry. Collaboration between the private sector and governments can accelerate the development of supportive policies, research and development efforts, and investment in Pleuromutilin Antibiotic market. Additionally, the growing consumer demand present avenues for market expansion.
The global Pleuromutilin Antibiotic market was valued at US$ 92 million in 2022 and is projected to reach US$ 111.6 million by 2029, at a CAGR of 5.3% during the forecast period.
Pleuromutilin’s market is driven by its effectiveness against specific bacterial infections and its widespread use in the veterinary and poultry medicine sectors. Its successful application in veterinary medicine and increasing demand have propelled market growth. Additionally, concerns about antibiotic resistance have prompted the livestock industry to adopt more sustainable veterinary medicines, with Pleuromutilin being considered a relatively low-resistance option, further boosting market demand. However, the Pleuromutilin market also faces several challenges. One of these challenges is the continuous rise in antibiotic resistance, which may limit its long-term effectiveness. Furthermore, some regions and markets may have stricter regulations on antibiotic use, posing challenges to market access for Pleuromutilin. Additionally, the veterinary sector’s interest in alternative treatment methods and greener veterinary medicines could impact the growth of the Pleuromutilin market. Therefore, the market needs to continually address challenges such as antibiotic resistance and regulatory restrictions to maintain sustainable growth.
Key Features:
The research report on the Pleuromutilin Antibiotic market includes several key features to provide comprehensive insights and facilitate decision-making for stakeholders.
Executive Summary: The report provides overview of the key findings, market trends, and major insights of the Pleuromutilin Antibiotic market.
Market Overview: The report provides a comprehensive overview of the Pleuromutilin Antibiotic market, including its definition, historical development, and current market size. It covers market segmentation by Type (e.g., Premix, API Powder), region, and application, highlighting the key drivers, challenges, and opportunities within each segment.
Market Dynamics: The report analyses the market dynamics driving the growth and development of the Pleuromutilin Antibiotic market. The report includes an assessment of government policies and regulations, technological advancements, consumer trends and preferences, infrastructure development, and industry collaborations. This analysis helps stakeholders understand the factors influencing the Pleuromutilin Antibiotic market’s trajectory.
Competitive Landscape: The report provides an in-depth analysis of the competitive landscape within the Pleuromutilin Antibiotic market. It includes profiles of major market players, their market share, strategies, product portfolios, and recent developments.
Market Segmentation and Forecast: The report segment the Pleuromutilin Antibiotic market based on various parameters, such as by Type, region, and by Application. It provides market size and growth forecasts for each segment, supported by quantitative data and analysis. This helps stakeholders identify growth opportunities and make informed investment decisions.
Technological Trends: The report should highlight the key technological trends shaping the Pleuromutilin Antibiotic market, such as advancements in Type One technology and emerging substitutes. It analyses the impact of these trends on market growth, adoption rates, and consumer preferences.
Market Challenges and Opportunities: The report identify and analyses the major challenges faced by the Pleuromutilin Antibiotic market, such as technical bottleneck, cost limitations, and high entry barrier. It also highlights the opportunities for market growth, such as government incentives, emerging markets, and collaborations between stakeholders.
Regulatory and Policy Analysis: The report should assess the regulatory and policy landscape for Pleuromutilin Antibiotic, including government incentives, emission standards, and infrastructure development plans. It should analyse the impact of these policies on market growth and provide insights into future regulatory developments.
Recommendations and Conclusion: The report conclude with actionable recommendations for stakeholders, such as Application One Consumer, policymakers, investors, and infrastructure providers. These recommendations should be based on the research findings and address key challenges and opportunities within the Pleuromutilin Antibiotic market.
Supporting Data and Appendices: The report include supporting data, charts, and graphs to substantiate the analysis and findings. It also includes appendices with additional detailed information, such as data sources, survey questionnaires, and detailed market forecasts.
Market Segmentation
Pleuromutilin Antibiotic market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
Market segment by Type
Premix
API Powder
Market segment by Application
Livestock
Poultry
Global Pleuromutilin Antibiotic Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Major players covered
Sunny Biotech
Hebei Weiyuan
Shandong Shengli
Shandong Lukang
Qingdao Dierman
Qilu Pharma
Huvepharma
Novartis
Vethellas
Elanco
Outline of Major Chapters:
Chapter 1: Introduces the definition of Pleuromutilin Antibiotic, market overview.
Chapter 2: Global Pleuromutilin Antibiotic market size in revenue and volume.
Chapter 3: Detailed analysis of Pleuromutilin Antibiotic manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Pleuromutilin Antibiotic in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Pleuromutilin Antibiotic capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.
1 Introduction to Research & Analysis Reports
1.1 Pleuromutilin Antibiotic Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Pleuromutilin Antibiotic Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Pleuromutilin Antibiotic Overall Market Size
2.1 Global Pleuromutilin Antibiotic Market Size: 2022 VS 2029
2.2 Global Pleuromutilin Antibiotic Revenue, Prospects & Forecasts: 2018-2029
2.3 Global Pleuromutilin Antibiotic Sales: 2018-2029
3 Company Landscape
3.1 Top Pleuromutilin Antibiotic Players in Global Market
3.2 Top Global Pleuromutilin Antibiotic Companies Ranked by Revenue
3.3 Global Pleuromutilin Antibiotic Revenue by Companies
3.4 Global Pleuromutilin Antibiotic Sales by Companies
3.5 Global Pleuromutilin Antibiotic Price by Manufacturer (2018-2023)
3.6 Top 3 and Top 5 Pleuromutilin Antibiotic Companies in Global Market, by Revenue in 2022
3.7 Global Manufacturers Pleuromutilin Antibiotic Product Type
3.8 Tier 1, Tier 2 and Tier 3 Pleuromutilin Antibiotic Players in Global Market
3.8.1 List of Global Tier 1 Pleuromutilin Antibiotic Companies
3.8.2 List of Global Tier 2 and Tier 3 Pleuromutilin Antibiotic Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type – Global Pleuromutilin Antibiotic Market Size Markets, 2022 & 2029
4.1.2 Premix
4.1.3 API Powder
4.2 By Type – Global Pleuromutilin Antibiotic Revenue & Forecasts
4.2.1 By Type – Global Pleuromutilin Antibiotic Revenue, 2018-2023
4.2.2 By Type – Global Pleuromutilin Antibiotic Revenue, 2024-2029
4.2.3 By Type – Global Pleuromutilin Antibiotic Revenue Market Share, 2018-2029
4.3 By Type – Global Pleuromutilin Antibiotic Sales & Forecasts
4.3.1 By Type – Global Pleuromutilin Antibiotic Sales, 2018-2023
4.3.2 By Type – Global Pleuromutilin Antibiotic Sales, 2024-2029
4.3.3 By Type – Global Pleuromutilin Antibiotic Sales Market Share, 2018-2029
4.4 By Type – Global Pleuromutilin Antibiotic Price (Manufacturers Selling Prices), 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application – Global Pleuromutilin Antibiotic Market Size, 2022 & 2029
5.1.2 Livestock
5.1.3 Poultry
5.2 By Application – Global Pleuromutilin Antibiotic Revenue & Forecasts
5.2.1 By Application – Global Pleuromutilin Antibiotic Revenue, 2018-2023
5.2.2 By Application – Global Pleuromutilin Antibiotic Revenue, 2024-2029
5.2.3 By Application – Global Pleuromutilin Antibiotic Revenue Market Share, 2018-2029
5.3 By Application – Global Pleuromutilin Antibiotic Sales & Forecasts
5.3.1 By Application – Global Pleuromutilin Antibiotic Sales, 2018-2023
5.3.2 By Application – Global Pleuromutilin Antibiotic Sales, 2024-2029
5.3.3 By Application – Global Pleuromutilin Antibiotic Sales Market Share, 2018-2029
5.4 By Application – Global Pleuromutilin Antibiotic Price (Manufacturers Selling Prices), 2018-2029
6 Sights by Region
6.1 By Region – Global Pleuromutilin Antibiotic Market Size, 2022 & 2029
6.2 By Region – Global Pleuromutilin Antibiotic Revenue & Forecasts
6.2.1 By Region – Global Pleuromutilin Antibiotic Revenue, 2018-2023
6.2.2 By Region – Global Pleuromutilin Antibiotic Revenue, 2024-2029
6.2.3 By Region – Global Pleuromutilin Antibiotic Revenue Market Share, 2018-2029
6.3 By Region – Global Pleuromutilin Antibiotic Sales & Forecasts
6.3.1 By Region – Global Pleuromutilin Antibiotic Sales, 2018-2023
6.3.2 By Region – Global Pleuromutilin Antibiotic Sales, 2024-2029
6.3.3 By Region – Global Pleuromutilin Antibiotic Sales Market Share, 2018-2029
6.4 North America
6.4.1 By Country – North America Pleuromutilin Antibiotic Revenue, 2018-2029
6.4.2 By Country – North America Pleuromutilin Antibiotic Sales, 2018-2029
6.4.3 US Pleuromutilin Antibiotic Market Size, 2018-2029
6.4.4 Canada Pleuromutilin Antibiotic Market Size, 2018-2029
6.4.5 Mexico Pleuromutilin Antibiotic Market Size, 2018-2029
6.5 Europe
6.5.1 By Country – Europe Pleuromutilin Antibiotic Revenue, 2018-2029
6.5.2 By Country – Europe Pleuromutilin Antibiotic Sales, 2018-2029
6.5.3 Germany Pleuromutilin Antibiotic Market Size, 2018-2029
6.5.4 France Pleuromutilin Antibiotic Market Size, 2018-2029
6.5.5 U.K. Pleuromutilin Antibiotic Market Size, 2018-2029
6.5.6 Italy Pleuromutilin Antibiotic Market Size, 2018-2029
6.5.7 Russia Pleuromutilin Antibiotic Market Size, 2018-2029
6.5.8 Nordic Countries Pleuromutilin Antibiotic Market Size, 2018-2029
6.5.9 Benelux Pleuromutilin Antibiotic Market Size, 2018-2029
6.6 Asia
6.6.1 By Region – Asia Pleuromutilin Antibiotic Revenue, 2018-2029
6.6.2 By Region – Asia Pleuromutilin Antibiotic Sales, 2018-2029
6.6.3 China Pleuromutilin Antibiotic Market Size, 2018-2029
6.6.4 Japan Pleuromutilin Antibiotic Market Size, 2018-2029
6.6.5 South Korea Pleuromutilin Antibiotic Market Size, 2018-2029
6.6.6 Southeast Asia Pleuromutilin Antibiotic Market Size, 2018-2029
6.6.7 India Pleuromutilin Antibiotic Market Size, 2018-2029
6.7 South America
6.7.1 By Country – South America Pleuromutilin Antibiotic Revenue, 2018-2029
6.7.2 By Country – South America Pleuromutilin Antibiotic Sales, 2018-2029
6.7.3 Brazil Pleuromutilin Antibiotic Market Size, 2018-2029
6.7.4 Argentina Pleuromutilin Antibiotic Market Size, 2018-2029
6.8 Middle East & Africa
6.8.1 By Country – Middle East & Africa Pleuromutilin Antibiotic Revenue, 2018-2029
6.8.2 By Country – Middle East & Africa Pleuromutilin Antibiotic Sales, 2018-2029
6.8.3 Turkey Pleuromutilin Antibiotic Market Size, 2018-2029
6.8.4 Israel Pleuromutilin Antibiotic Market Size, 2018-2029
6.8.5 Saudi Arabia Pleuromutilin Antibiotic Market Size, 2018-2029
6.8.6 UAE Pleuromutilin Antibiotic Market Size, 2018-2029
7 Manufacturers & Brands Profiles
7.1 Sunny Biotech
7.1.1 Sunny Biotech Company Summary
7.1.2 Sunny Biotech Business Overview
7.1.3 Sunny Biotech Pleuromutilin Antibiotic Major Product Offerings
7.1.4 Sunny Biotech Pleuromutilin Antibiotic Sales and Revenue in Global (2018-2023)
7.1.5 Sunny Biotech Key News & Latest Developments
7.2 Hebei Weiyuan
7.2.1 Hebei Weiyuan Company Summary
7.2.2 Hebei Weiyuan Business Overview
7.2.3 Hebei Weiyuan Pleuromutilin Antibiotic Major Product Offerings
7.2.4 Hebei Weiyuan Pleuromutilin Antibiotic Sales and Revenue in Global (2018-2023)
7.2.5 Hebei Weiyuan Key News & Latest Developments
7.3 Shandong Shengli
7.3.1 Shandong Shengli Company Summary
7.3.2 Shandong Shengli Business Overview
7.3.3 Shandong Shengli Pleuromutilin Antibiotic Major Product Offerings
7.3.4 Shandong Shengli Pleuromutilin Antibiotic Sales and Revenue in Global (2018-2023)
7.3.5 Shandong Shengli Key News & Latest Developments
7.4 Shandong Lukang
7.4.1 Shandong Lukang Company Summary
7.4.2 Shandong Lukang Business Overview
7.4.3 Shandong Lukang Pleuromutilin Antibiotic Major Product Offerings
7.4.4 Shandong Lukang Pleuromutilin Antibiotic Sales and Revenue in Global (2018-2023)
7.4.5 Shandong Lukang Key News & Latest Developments
7.5 Qingdao Dierman
7.5.1 Qingdao Dierman Company Summary
7.5.2 Qingdao Dierman Business Overview
7.5.3 Qingdao Dierman Pleuromutilin Antibiotic Major Product Offerings
7.5.4 Qingdao Dierman Pleuromutilin Antibiotic Sales and Revenue in Global (2018-2023)
7.5.5 Qingdao Dierman Key News & Latest Developments
7.6 Qilu Pharma
7.6.1 Qilu Pharma Company Summary
7.6.2 Qilu Pharma Business Overview
7.6.3 Qilu Pharma Pleuromutilin Antibiotic Major Product Offerings
7.6.4 Qilu Pharma Pleuromutilin Antibiotic Sales and Revenue in Global (2018-2023)
7.6.5 Qilu Pharma Key News & Latest Developments
7.7 Huvepharma
7.7.1 Huvepharma Company Summary
7.7.2 Huvepharma Business Overview
7.7.3 Huvepharma Pleuromutilin Antibiotic Major Product Offerings
7.7.4 Huvepharma Pleuromutilin Antibiotic Sales and Revenue in Global (2018-2023)
7.7.5 Huvepharma Key News & Latest Developments
7.8 Novartis
7.8.1 Novartis Company Summary
7.8.2 Novartis Business Overview
7.8.3 Novartis Pleuromutilin Antibiotic Major Product Offerings
7.8.4 Novartis Pleuromutilin Antibiotic Sales and Revenue in Global (2018-2023)
7.8.5 Novartis Key News & Latest Developments
7.9 Vethellas
7.9.1 Vethellas Company Summary
7.9.2 Vethellas Business Overview
7.9.3 Vethellas Pleuromutilin Antibiotic Major Product Offerings
7.9.4 Vethellas Pleuromutilin Antibiotic Sales and Revenue in Global (2018-2023)
7.9.5 Vethellas Key News & Latest Developments
7.10 Elanco
7.10.1 Elanco Company Summary
7.10.2 Elanco Business Overview
7.10.3 Elanco Pleuromutilin Antibiotic Major Product Offerings
7.10.4 Elanco Pleuromutilin Antibiotic Sales and Revenue in Global (2018-2023)
7.10.5 Elanco Key News & Latest Developments
8 Global Pleuromutilin Antibiotic Production Capacity, Analysis
8.1 Global Pleuromutilin Antibiotic Production Capacity, 2018-2029
8.2 Pleuromutilin Antibiotic Production Capacity of Key Manufacturers in Global Market
8.3 Global Pleuromutilin Antibiotic Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Pleuromutilin Antibiotic Supply Chain Analysis
10.1 Pleuromutilin Antibiotic Industry Value Chain
10.2 Pleuromutilin Antibiotic Upstream Market
10.3 Pleuromutilin Antibiotic Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Pleuromutilin Antibiotic Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer